OBJECTIVE:Cognitive behavioral therapy (CBT) is an empirically supported treatment for social phobia. However, not all individuals respond to treatment and many who show improvement do not maintain their gains over the long-term. Thus, alternative treatments are needed. METHOD: The current study (N = 87) was a 3-arm randomized clinical trial comparing CBT, acceptance and commitment therapy (ACT), and a wait-list control group (WL) in participants with a diagnosis of social phobia based on criteria of the Diagnostic and Statistical Manual of Mental Disorders (4th ed.; American Psychiatric Association, 1994). Participants completed 12 sessions of CBT or ACT or a 12-week waiting period. All participants completed assessments at baseline and posttreatment, and participants assigned to CBT and ACT also completed assessments 6 and 12 months following baseline. Assessments consisted of self-report measures, a public-speaking task, and clinician ratings. RESULTS: Multilevel modeling was used to examine between-group differences on outcomes measures. Both treatment groups outperformed WL, with no differences observed between CBT and ACT on self-report, independent clinician, or public-speaking outcomes. Lower self-reported psychological flexibility at baseline was associated with greater improvement by the 12-month follow-up in CBT compared with ACT. Self-reported fear of negative evaluation significantly moderated outcomes as well, with trends for both extremes to be associated with superior outcomes from CBT and inferior outcomes from ACT. Across treatment groups, higher perceived control and extraversion were associated with greater improvement, whereas comorbid depression was associated with poorer outcomes. CONCLUSIONS: Implications for clinical practice and future research are discussed.
RCT Entities:
OBJECTIVE: Cognitive behavioral therapy (CBT) is an empirically supported treatment for social phobia. However, not all individuals respond to treatment and many who show improvement do not maintain their gains over the long-term. Thus, alternative treatments are needed. METHOD: The current study (N = 87) was a 3-arm randomized clinical trial comparing CBT, acceptance and commitment therapy (ACT), and a wait-list control group (WL) in participants with a diagnosis of social phobia based on criteria of the Diagnostic and Statistical Manual of Mental Disorders (4th ed.; American Psychiatric Association, 1994). Participants completed 12 sessions of CBT or ACT or a 12-week waiting period. All participants completed assessments at baseline and posttreatment, and participants assigned to CBT and ACT also completed assessments 6 and 12 months following baseline. Assessments consisted of self-report measures, a public-speaking task, and clinician ratings. RESULTS: Multilevel modeling was used to examine between-group differences on outcomes measures. Both treatment groups outperformed WL, with no differences observed between CBT and ACT on self-report, independent clinician, or public-speaking outcomes. Lower self-reported psychological flexibility at baseline was associated with greater improvement by the 12-month follow-up in CBT compared with ACT. Self-reported fear of negative evaluation significantly moderated outcomes as well, with trends for both extremes to be associated with superior outcomes from CBT and inferior outcomes from ACT. Across treatment groups, higher perceived control and extraversion were associated with greater improvement, whereas comorbid depression was associated with poorer outcomes. CONCLUSIONS: Implications for clinical practice and future research are discussed.
Authors: Josien Schuurmans; Hannie Comijs; Paul M G Emmelkamp; Ingrid J C Weijnen; Marcel van den Hout; Richard van Dyck Journal: Int Psychogeriatr Date: 2009-12 Impact factor: 3.878
Authors: Jonathan R T Davidson; Edna B Foa; Jonathan D Huppert; Francis J Keefe; Martin E Franklin; Jill S Compton; Ning Zhao; Kathryn M Connor; Thomas R Lynch; Kishore M Gadde Journal: Arch Gen Psychiatry Date: 2004-10
Authors: Maria Tillfors; Per Carlbring; Tomas Furmark; Susanne Lewenhaupt; Maria Spak; Anna Eriksson; Bengt E Westling; Gerhard Andersson Journal: Depress Anxiety Date: 2008 Impact factor: 6.505
Authors: Heejung Park; Jessica J Chiang; Michael R Irwin; Julienne E Bower; Heather McCreath; Andrew J Fuligni Journal: Sleep Med Date: 2019-04-19 Impact factor: 3.492
Authors: Carolyn D Davies; Katherine Young; Jared B Torre; Lisa J Burklund; Philippe R Goldin; Lily A Brown; Andrea N Niles; Matthew D Lieberman; Michelle G Craske Journal: J Affect Disord Date: 2016-11-16 Impact factor: 4.839
Authors: Christina F Sandman; Katherine S Young; Lisa J Burklund; Darby E Saxbe; Matthew D Lieberman; Michelle G Craske Journal: Behav Res Ther Date: 2020-03-29
Authors: Jonah N Cohen; Carrie M Potter; Deborah A G Drabick; Carlos Blanco; Franklin R Schneier; Michael R Liebowitz; Richard G Heimberg Journal: Psychiatry Res Date: 2015-04-16 Impact factor: 3.222